- Home
- EEX vs MDXG Comparison
EEX vs MDXG Comparison
Compare EEX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEX
- MDXG
- Stock Information
- Founded
- EEX 2013
- MDXG 2006
- Country
- EEX United States
- MDXG United States
- Employees
- EEX N/A
- MDXG N/A
- Industry
- EEX Advertising
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- EEX Consumer Discretionary
- MDXG Health Care
- Exchange
- EEX Nasdaq
- MDXG Nasdaq
- Market Cap
- EEX 910.8M
- MDXG 877.4M
- IPO Year
- EEX 2017
- MDXG N/A
- Fundamental
- Price
- EEX $5.15
- MDXG $6.96
- Analyst Decision
- EEX Strong Buy
- MDXG Strong Buy
- Analyst Count
- EEX 2
- MDXG 2
- Target Price
- EEX $7.90
- MDXG $12.50
- AVG Volume (30 Days)
- EEX 100.8K
- MDXG 743.2K
- Earning Date
- EEX 08-06-2025
- MDXG 07-30-2025
- Dividend Yield
- EEX 1.18%
- MDXG N/A
- EPS Growth
- EEX N/A
- MDXG N/A
- EPS
- EEX 0.02
- MDXG 0.27
- Revenue
- EEX $413,100,000.00
- MDXG $352,375,000.00
- Revenue This Year
- EEX $14.85
- MDXG $9.55
- Revenue Next Year
- EEX $6.42
- MDXG $11.43
- P/E Ratio
- EEX $207.04
- MDXG $25.49
- Revenue Growth
- EEX 4.87
- MDXG 5.34
- 52 Week Low
- EEX $3.22
- MDXG $5.47
- 52 Week High
- EEX $6.65
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- EEX 65.14
- MDXG 68.79
- Support Level
- EEX $5.11
- MDXG $5.86
- Resistance Level
- EEX $5.30
- MDXG $6.42
- Average True Range (ATR)
- EEX 0.14
- MDXG 0.24
- MACD
- EEX 0.02
- MDXG 0.14
- Stochastic Oscillator
- EEX 85.29
- MDXG 92.86
About EEX Emerald Holding Inc.
Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.